Headquartered in New York, NY Fiscal year ends December NASDAQ: CNTN cantonstrategic.com
Canton Strategic Holdings, Inc. (Nasdaq: CNTN) is a publicly traded company focused on supporting the Canton Network, a blockchain infrastructure designed to digitize traditional financial markets. The Company operates as a Super Validator on the Canton Network, earning Canton Coin (CC) rewards for providing validation and liveness services. It also offers a locking-as-a-service (LaaS) product, whereby it locks its own CC on behalf of other network participants—Super Validators and Featured Applications—who are required to maintain minimum locked CC balances under network governance rules. The Company maintains a substantial digital asset treasury of Canton Coin. Previously a clinical-stage biotechnology company, Canton Strategic completed its strategic pivot by divesting its legacy biotech subsidiary Gravitas Life Sciences in July 2026. The Company generates revenue through network validation rewards, interest on locked CC, shares of customers' network rewards, and equity grants from LaaS contracts. Updated
JPMorgan, Citi, Barclays, and 17 other financial giants just signed onto DTCC's blockchain settlement platform, yet the coin powering that network keeps sliding deeper into the red. Something about how these banks…
Canton Strategic Holdings, Inc. (Nasdaq: CNTN) is a publicly traded company focused on supporting the Canton Network, a blockchain infrastructure designed to digitize traditional financial markets.
